Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sonic Healthcare Limited ( (AU:SHL) ) has shared an update.
Sonic Healthcare Limited announced a change in the director’s interest, with James Pacey Newcombe acquiring 345,342 unlisted options and 50,481 unlisted performance rights over ordinary shares. These securities will vest in 2028, contingent on performance criteria, as part of the company’s long-term incentive plan approved at the 2025 AGM. This move reflects the company’s strategy to align executive compensation with performance, potentially impacting its operational focus and stakeholder interests by incentivizing leadership to meet long-term goals.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$23.50 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited operates in the healthcare industry, primarily focusing on providing medical diagnostic services. The company is known for its comprehensive range of laboratory and radiology services, catering to a wide market that includes hospitals, medical practitioners, and patients globally.
Average Trading Volume: 1,683,183
Technical Sentiment Signal: Sell
Current Market Cap: A$11.41B
For detailed information about SHL stock, go to TipRanks’ Stock Analysis page.